Description
Ostarine (MK-2866) Research Chemical
Ostarine (MK-2866, Enobosarm) is a selective androgen receptor modulator developed by GTx, Inc. It has the most extensive clinical research record of any SARM, including Phase II trials in cancer cachexia and muscle wasting (Papanicolaou et al., 2013). It reached Phase III development — further advanced than any other SARM.
Research Applications
- Muscle wasting and cachexia models (Phase II data available)
- Cancer cachexia research — most translatable SARM data set
- Bone density models
- AR agonism with high tissue selectivity vs testosterone
- Stress urinary incontinence research models
Product Specifications
- Purity: ≥98% HPLC confirmed
- Identity: Mass spectrometry (MW: 389.33)
- Certificate of Analysis: Independent third-party lab
- Form: Lyophilized powder, sealed glass vial
For Research Use Only (RUO). Not for human consumption.
